Chemodex

Naringin

CHF 108.00
In stock
CDX-N0234-G100100 gCHF 108.00
More Information
Product Details
Synonyms 4',5,7-Trihydroxyflavanone 7-rhamnoglucoside; Naringenin 7-neohesperidoside; Naringenine-7-rhamnosidoglucoside; Naringoside; NSC 5548
Product Type Chemical
Properties
Formula

C27H32O14

MW 580.54
CAS 10236-47-2
RTECS QN6340000
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance Light yellow to beige powder.
Solubility Soluble in DMSO (10mg/ml), DMF (20mg/ml) or ethanol (1mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key DFPMSGMNTNDNHN-JJLSSNRUSA-N
Smiles OC1=C2C(OC(C3=CC=C(O)C=C3)CC2=O)=CC(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

Naringin is a citrus-derived flavonoid (bitter principal). It undergoes extensive metabolism in the liver. It has a broad panel of properties, including anti-inflammatory, antioxidant, anticancer, antidiabetic, cardioprotective, bone regenerative and neuroprotective activities. Naringin acts by modulating several signaling pathway targets, activity is primarily attributed to its anti-inflammatory (via inhibiting recruitment of cytokines and inflammatory transcription factors) and antioxidant (via scavenging of free radicals, bolstering of endogenous antioxidant defense system and metal ion chelation) effects. It increases the expression of neurotrophic factor in dopaminergic neurons, providing neuroprotection.

Product References

(1) U. Fuhr, et al.; Br. J. Clin. Pharmacol. 35, 431 (1993) | (2) P.C. Ho & D.J. Saville; J. Pharm. Pharmaceut. Sci. 4, 217 (2001) | (3) S. Bharti, et al.; Planta Med. 80, 437 (2014) (Review) | (4) U.J. Jung, et al.; Exp. Neurobiol. 23, 124 (2014) (Review) | (5) M.A. Alam, et al.; Adv. Nutr. 5, 404 (2014) (Review) | (6) R. Chen, et al.; Pharm. Biol. 54, 3203 (2016) (Review)

  1. Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer: D.M. El-Kersh, et al.; Nature Sci. Rep. 11, 7121 (2021)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.